BenjaminMauriceSolomonMD

PubMed

• Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit...
  Vladimir Lazar, Nicolas Girard, Eric Raymond, Jean-François Martini, Susan Galbraith, Jacques Raynaud, Catherine Bresson, Benjamin Solomon, Shai Magidi, Hovav Nechusht...> ;JCO Precision Oncology. 2022 Sep 1
• 3 citations
  A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer.
  Benjamin Solomon, Ana Callejo, Jair Bar, Guy Berchem, Lyudmila Bazhenova, Pierre Saintigny, Fanny Wunder, Jacques Raynaud, Nicolas Girard, J Jack Lee, Raed Sulaiman, B...> ;Cancer Medicine. 2022 Jul 1
• 4 citations
  A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-Immunofluorescence.
  Raed Sulaiman, Pradip De, Jennifer C Aske, Xiaoqian Lin, Adam Dale, Ethan Vaselaar, Nischal Koirala, Cheryl Ageton, Kris Gaster, Joshua Plorde, Benjamin Solomon, Bradl...> ;Cancers. 2022 Jun 10
• 1 citations
  Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high-expressing normal lung.
  Vladimir Lazar, Jacques Raynaud, Shai Magidi, Catherine Bresson, Jean-François Martini, Susan Galbraith, Fanny Wunder, Amir Onn, Gerald Batist, Nicolas Girard, Ulrik L...> ;Therapeutic Advances in Medical Oncology. 2022 Jan 1
• 24 citations
  Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers.
  Alexander Drilon, Daniel S W Tan, Ulrik N Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D Patel, Lee Rosen, Benjamin Solomon, Ricarda Norenberg, Laura Dima, Nicoletta Breg...> ;JCO Precision Oncology. 2022 Jan 1
• 34 citations
  Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.
  Jason K. Sicklick, Shumei Kato, Ryosuke Okamura, Hitendra Patel, Mina Nikanjam, Paul T. Fanta, Michael E. Hahn, Pradip De, Casey Williams, Jessica Guido, Benjamin M. S...> ;Genome Medicine. 2021 Oct 4
• 4 citations
  Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival.
  Vladimir Lazar, Shai Magidi, Nicolas Girard, Alexia Savignoni, Jean-Francois Martini, Giorgio Massimini, Catherine Bresson, Raanan Berger, Amir Onn, Jacques Raynaud, F...> ;NPJ Precision Oncology. 2021 Apr 28
• 4 citations
  Complete and Prolonged Response of Renal Cell Carcinoma With Rhabdoid Features to Checkpoint Inhibitor Therapy.
  Emily Wynja, Benjamin Maurice Solomon, Jonathan Bleeker> ;Journal of Immunotherapy. 2018 Sep 1
• 37 citations
  Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis.
  Benjamin Maurice Solomon, Kari G. Chaffee, Jonathan Moreira, Susan M. Schwager, James R. Cerhan, Timothy G. Call, Neil E. Kay, Susan L. Slager, Tait D. Shanafelt> ;Leukemia. 2016 Feb 1
• Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphoma.
  Richly H, Kim TM, Schuler M, Kim D, Harrison SJ, Shaw AT, Boral AL, Yovine A, Solomon B> ;Blood. 2015-09-03
• Validating ROS1 rearrangements as a therapeutic target in non-small-cell lung cancer.
  Solomon B> ;J. Clin. Oncol.. 2015-03-20
• Current status of targeted therapy for anaplastic lymphoma kinase-rearranged non-small cell lung cancer.
  Solomon B, Wilner KD, Shaw AT> ;Clin. Pharmacol. Ther.. 2014-01-01
• 47 citations
  Overall and Cancer-Specific Survival of Patients With Breast, Colon, Kidney, and Lung Cancers With and Without Chronic Lymphocytic Leukemia: A SEER Population-Based Study
  Benjamin Maurice Solomon, Kari G. Rabe, Susan L. Slager, Jerry D. Brewer, James R. Cerhan, Tait D. Shanafelt> ;Journal of Clinical Oncology. 2013 Mar 1
• Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.
  Camidge DR, Bang Y, Kwak EL, Iafrate AJ, Varella-Garcia M, Fox SB, Riely GJ, Solomon B, Ou SI, Kim D, Salgia R, Fidias P, Engelman JA, Gandhi L, Jänne PA, Costa DB, Sh...> ;Lancet Oncol.. 2012-10-01
• Progress in molecular targeted therapy for thyroid cancer: vandetanib in medullary thyroid cancer.
  Solomon B, Rischin D> ;J. Clin. Oncol.. 2012-01-10
• Are anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer prognostic, predictive, or both?
  Solomon B, Shaw AT> ;J Thorac Oncol. 2012-01-01
• Crizotinib and testing for ALK.
  Shaw AT, Solomon B, Kenudson MM> ;J Natl Compr Canc Netw. 2011-12-01
• Targeting anaplastic lymphoma kinase in lung cancer.
  Shaw AT, Solomon B> ;Clin. Cancer Res.. 2011-04-15
• 8 citations
  Epidermal growth factor receptor (EGFR) inhibitor-induced rash: a consecutive patient series that illustrates the need for rigorous palliative trials.
  Benjamin Maurice Solomon, Aminah Jatoi> ;Journal of Palliative Medicine. 2011 Feb 12
• Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
  Kwak EL, Bang Y, Camidge DR, Shaw AT, Solomon B, Maki RG, Ou SI, Dezube BJ, Jänne PA, Costa DB, Varella-Garcia M, Kim W, Lynch TJ, Fidias P, Stubbs H, Engelman JA, Seq...> ;N. Engl. J. Med.. 2010-10-28
• 1442 citations
  Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
  Alice T. Shaw, Beow Y. Yeap, Mari Mino-Kenudson, Subba R. Digumarthy, Daniel B. Costa, Rebecca S. Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott...> ;Journal of Clinical Oncology. 2009 Sep 10
• Clinical activity observed in a phase I dose escalation trial of an oral c-met and ALK inhibitor, PF-02341066.
  Kwak EL, Camidge DR, Clark J, Shapiro GI, Maki RG, Ratain MJ, Solomon B, Bang Y, Ou S, Salgia R> ;J. Clin. Oncol.. 2009-05-20
• 17 citations
  Rash from EGFR inhibitors: Opportunities and challenges for palliation
  Benjamin Maurice Solomon, Aminah Jatoi> ;Current Oncology Reports. 2008 Oct 12
• The influence of efaproxiral on breast cancer xenograft hypoxia and HIF-1-alpha expression.
  Kavanagh BD, Steffen RP, Frederick B, Solomon B, Chan D> ;J. Clin. Oncol.. 2006-06-20
• Prediction of clinical outcome in non-small cell lung cancer (NSCLC) patients treated with gefitinib using Matrix-Assisted Laser Desorption/Ionization-Time of Flight M...
  Solomon B, Gregorc V, Taguchi F, Kasahara K, Nishio M, Roder H, Hirsch FR, Duncan MW, Bunn PA, Carbone DP> ;J. Clin. Oncol.. 2006-06-20
• Join now to see all